Table 2 Clinical characteristics of ITP patients with high lipid levels and normal lipid levels
From: Hyperlipidemia in immune thrombocytopenia: a retrospective study
| Â | High lipid | Normal lipid | P |
|---|---|---|---|
Age (median, interquartile range) | 54 (18.5) | 52 (34.5) | 0.488 |
Gender(male %) | 65 (42.5%) | 62 (41.6%) | 0.725 |
ITP duration (months) (mean ± SEM) | 50.5 ± 8.89 | 27.53 ± 5.59 | 0.03* |
Initial platelet counts (×109/L) (mean ± SEM) | 18.31 ± 2.21 | 19.98 ± 1.880 | 0.57 |
Platelet counts after treatment (×109/L) (mean ± SEM) | 74.16 ± 5.30 | 98.27 ± 6.87 | 0.0057** |
Severe bleeding (n, %) | 51 (33.3%) | 22 (14.8%) | 0.0001*** |
Corticosteroid treatment (R, %) | 107 (81.1%) | 99 (85.34%) | 0.4 |
TPO agent treatment (R, %) | 53 (58.9%) | 49 (75.4%) | 0.04* |
Refractory (n, %) | 25 (16.3%) | 4 (2.68%) | 0.0001*** |